ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2495

Ankylosing Spondylitis Protective Endoplasmic Reticulum Aminopeptidase 1 Variants Lead To Decreased Natural Killer Cell Conjugation and Activation

Hasan Abdullah1, Zhenbo Zhang2, Robert Inman3 and Nigil Haroon4, 1IMS, University of Toronto, Toronto, ON, Canada, 2Toronto Western Research Institute, Toronto, ON, Canada, 3Immunlogy and Institute of Medical Science, University of Toronto and Toronto Western Hospital, Toronto, ON, Canada, 4Medicine/Rheumatology, Toronto Western Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), chemokines, human leukocyte antigens (HLA) and natural killer (NK) cells, KIR (Killer Ig like receptor)

  • Tweet
  • Email
  • Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis: Pathogenesis, Etiology, Animal Models II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

 

Ankylosing Spondylitis (AS) is an inflammatory arthritis affecting the axial and peripheral joints. Human Leukocyte Antigen (HLA)-B27 and Endoplasmic Reticulum Aminopeptidase (ERAP) 1 genes are strongly associated with AS. An AS pathogenesis mechanism proposes that variant forms of HLA-B27 including B27 free heavy chains (FHC) can be recognized by Natural Killer (NK) cells through receptors like KIR3DL1and KIR3DL2, and could be pathogenic. ERAP1 variants K528R and Q730E with decreased function are protective in AS. Decreased function results in higher HLA-B27 (FHC) expression and can bind to the inhibitory receptors KIR3DL1 and KIR3DL2 altering NK cell activation.

Methods:

C1R cells stably expressing HLA-B27 were transfected with ERAP1shRNA to silence the endogenous ERAP1 expression. These cells were transfected with either the common or one of the rare AS associated ERAP1 variants K528R / Q730E. The target cell line was co-cultured with both a KIR3DL1 expressing as well as a non-KIR3DL1 expressing YTS NK cell line for 9 hours. Supernatants were analyzed for 64 cytokines and chemokines using a bead based multiplex assay. Separately, co-cultured cells were stained for intracellular Macrophage Inflammatory Protein (MIP)-1α. NK cells and target cells were each labeled with separate surface staining fluorescent dyes before co-culture. Co-cultured cells were analyzed by flow cytometry at baseline and after 5 and 10 minutes of co-incubation, for NK cell-target cell conjugate formation. Activation of NK cells was also analyzed by flow cytometry after staining for the degranulation marker CD107a. 

Results:

Duplicate results of the multiplexing assay show MIP-1α is reduced when C1R-B2705 + wild type ERAP1, C1RB2705 + ERAP1 K528R, and C1RB2705 + ERAP1 Q730E cells were co-cultured with 3DL1 NK cells in comparison to YTS NK cells (60%, 45% and 40% reduction respectively). Conjugate formation with the passage of co-incubation time is also reduced in the variant co-cultures as a result of KIR3DL1 interaction (K528R: 27%, Q730E: 18% reduction). Intracellular staining for NK cell MIP-1α production in the above co-cultures revealed a corresponding inhibition of MIP-1α (K528R: 4.6%, Q730E: 28% reduction). YTS-3DL1 NK cell CD107a expression trends lower in the ERAP1 variants in comparison to wild type ERAP1.

Conclusion:

Our results are a logical extension of our previous results that showed protective ERAP1 variants lead to increased surface HLA-B27 FHC in monocytes. Here we show that the protective ERAP1 variants, when expressed in C1R cells, result in decreased conjugate formation with KIR3DL1 expressing NK cells, in comparison to wild type ERAP1. A corresponding decrease in MIP-1α chemokine expression and NK cell activation was observed. Reduced function ERAP1 variants may be protective in AS because increased surface HLA-B27 FHC can interact with inhibitory NK cell receptors like KIR3DL1 and cause reduced conjugate formation and NK cell suppression. 


Disclosure:

H. Abdullah,
None;

Z. Zhang,
None;

R. Inman,
None;

N. Haroon,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ankylosing-spondylitis-protective-endoplasmic-reticulum-aminopeptidase-1-variants-lead-to-decreased-natural-killer-cell-conjugation-and-activation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology